HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$4.25
Day range
$4.31 - $4.64
Year range
$3.79 - $12.36
Market cap
1.85B USD
Avg Volume
22.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.74M | 6.89% |
Operating expense | 54.65M | 74.00% |
Net income | -202.49M | -121.60% |
Net profit margin | -1.37K | -107.31% |
Earnings per share | -0.50 | -28.21% |
EBITDA | -172.04M | -93.38% |
Effective tax rate | 0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 500.45M | 68.89% |
Total assets | 1.31B | 133.98% |
Total liabilities | 371.29M | 136.95% |
Total equity | 933.95M | — |
Shares outstanding | 406.92M | — |
Price to book | 1.85 | — |
Return on assets | -34.75% | — |
Return on capital | -44.09% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -202.49M | -121.60% |
Cash from operations | -131.96M | -28.99% |
Cash from investing | -7.27M | -9.27% |
Cash from financing | 40.53M | 191.62% |
Net change in cash | -93.87M | 1.48% |
Free cash flow | -73.85M | -16.66% |
About
Founded
2013
Headquarters
Website
Employees
800
